RedHill Biopharma (RDHL) Posts Q1 Loss of 5c/Share

RedHill Biopharma (NASDAQ: RDHL) reported Q1 EPS of ($0.05), $0.42 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.

You May Also Be Interested In

• Delta Air Lines stock climbs on earnings beat and strong guidance
• BTIG Starts Equinix (EQIX) at Buy
• Cohu (COHU) PT Raised to $70 at Stifel on Expectation of 'More Buoyant Multiple'